The pharmacokinetic parameters of sisomicin (SISO) were studied in total 23 patients with normal renal function and with various degrees of renal impairment including patients under maintenance hemodialysis and continuous ambulatory peritoneal dialysis.In all cases 1 mg/kg of SISO was intra. venously administered with one hour constant infusion.
Serum concentration of SISO were determined by the high performance liquid chromatography method and pharmacokinetic parameters were obtained following the one-compartment model.The results were as follows:
1.In patients with normal renal function (mean creatinine clearance (Ccr): 98.0±26.1 ml/min), the mean peak concentration was 4.7±1.4μg/ml and the serum half-life (T
1/2) was 2.2±1.0hours.The apparent volume of distribution (V
d) was 10.1±5.5 1, i.e. 22.9±18.2%, of body weight.In case of renal impairment, the mean peak concentration was 4.1±1.4μg/ml in patients with Ccr of 45 to 69 ml/min and 4.9±2.1 μg/ml in patients with Ccr of 10 to 44 ml/min.T
1/2 was 2.1±0.7 hours and 12.4±6.8 hours, respectively.The volume of distribution (V
d) was 7.7±1.6 1, i.e.19.1±7.2% of body weight and 8.7±3.9 1, i.e.18.3±9.0% of body weight, respectively.
In patients under maintenance hemodialysis, the mean peak level and T
1/2 during interdialysis period were 4.5±1.5 μg/ml and 33.9±19.0 hours.V
d was 15.4±5.5 1, i.e.29.9±8.0% of body weight.
2. The renal insufficiency did not significantly affect the serum peak concentration and V
d However, plasma SISO concentration at two hours after the start of SISO infusion showed a significant correlation (r=0.750) with serum creatinine concentration.As shown in Fig.4, the correlation coefficient between plasma SISO concentration and serum creatinine concentration increased gradually, and reached to 0.843 at six hours.
3. When the SISO
T1/2 was compared with serum creatinine concentration, there was a good correlation (r=0.918
Y (
T1/2 in hours) =5.2×
X (serum creatinine concentration in mg/dl)-2.8)(Fig.3).
4. For patients with impaired renal function, to obtain proper peak and trough concentration, only the prolongation of dosing intervals would be sufficient adjusting by the serum creatinine levels according to ZASKE's method.
View full abstract